Page last updated: 2024-08-22

nitroxoline and cyclin d1

nitroxoline has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, WL; Chen, CS; Guh, JH; Hsu, LC; Leu, WJ	1

Other Studies

1 other study(ies) available for nitroxoline and cyclin d1

Article	Year
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation. Oncotarget, 2015, Nov-24, Volume: 6, Issue:37 Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Blotting, Western; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Cyclin D1; DNA Damage; Drug Repositioning; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Humans; Male; Microscopy, Fluorescence; Nitroquinolines; Prostatic Neoplasms; Retinoblastoma Protein; RNA Interference; Signal Transduction; TOR Serine-Threonine Kinases	2015

Article

Year

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.

Oncotarget, 2015, Nov-24, Volume: 6, Issue:37

Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Blotting, Western; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Cyclin D1; DNA Damage; Drug Repositioning; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Humans; Male; Microscopy, Fluorescence; Nitroquinolines; Prostatic Neoplasms; Retinoblastoma Protein; RNA Interference; Signal Transduction; TOR Serine-Threonine Kinases

2015